comparemela.com

Latest Breaking News On - Charlson deyo comorbidity index - Page 2 : comparemela.com

Immunotherapy After Chemoradiation Improves Survival in Stage III NSCLC

Immunotherapy after chemoradiation provides a survival benefit in unresectable, stage III non-small cell lung cancer, real-world data suggest.

United-states
National-cancer-database
National-cancer
Charlson-deyo-comorbidity-index

Parathyroidectomy Reduces Fractures in Primary Hyperparathyroidism

Hip and other fractures occurred less often in older adults following parathyroidectomy, suggesting a clinically meaningful benefit of the operation.

Charlson-deyo-comorbidity-index

COVID-19 Scan for Oct 29, 2021

COVID-19 Scan for Oct 29, 2021
umn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umn.edu Daily Mail and Mail on Sunday newspapers.

Texas
United-states
Us-government-accountability-office
Health-administration
University-of-texas-md-anderson-cancer-center
Cancer-center
Charlson-deyo-comorbidity-index
Accountability-office
Occupational-safety

Studies link some drugs, non-white race with higher risk of COVID death

recep aktas / iStock Two new US studies identify risk factors for COVID-19 death, one pointing to the use of certain medications and the other describing development of a risk calculator that showed elevated risk in non-white populations and in people with underlying conditions and social deprivation. Hydroxychloroquine, azithromycin combo The first study, published yesterday in JAMA Network Open, found that use of a combination of the antimalarial drug hydroxychloroquine and the antibiotic azithromycin was linked to increased risk of death in hospitalized COVID-19 patients, while cholesterol-lowering statin drugs, vitamin C or D, and the cardiovascular drugs angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers appeared protective.

North-carolina
United-states
Miami
Florida
Philadelphia
Pennsylvania
Americans
Johns-hopkins-university
Premier-applied-sciences
Charlson-deyo-comorbidity-index
Nature-medicine

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.